Steve Jobs’s Hottest App May Be Succession Plan: Eric Jackson
This article is for subscribers only.
Apple Inc. suffers from a Steve Jobs discount, and it’s not fair.
Ever since Jobs, the chief executive officer, disclosed that he had a rare form of pancreatic cancer in August 2004, Apple’s stock has been underpriced. That assertion may seem absurd, given that the shares have risen more than 2,000 percent since then and the company’s market value of $325 billion is second only to that of Exxon Mobil Corp. Apple’s share price is now hovering at about $355.